Endocrine system

Endocrine system

Alogliptin for diabetes mellitus
Canagliflozin for type 2 diabetes mellitus
Dapagliflozin for T2DM TAs 390 288 & 418 (Decision document)
Dapagliflozin with insulin for treating type 1 diabetes
Denosumab for bone loss in men with Prostate Cancer - September 2010 - Please see Malignant disease and immunosupression
Denosumab for the prevention of osteoporotic fractures in men and postmenopausal women - September 2013 - Updated September 2014
          Transfer of Care Guideline
          Template Letter
Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours - NICE TA265 - Please see Malignant disease and immunosupression
Diabetes Clinical Guidelines - June 2010
          Blood Glucose Monitoring - Blood Glucose Monitoring Systems for Type 2 diabetes
          Diabetes Service - June 2010 - Patient Information Leaflet
          Diabetes Blood Glucose Meters & Test Strips - April 2010 - Patient Information Leaflet
DPP-4 Inhibitors (Gliptins) summary
Dulaglutide (Trulicity) for type 2 diabetes
Empagliflozin for type 2 diabetes mellitus
Ertugliflozin for type 2 diabetes
Exenatide - November 2008
          Exenatide shared care protocol
Exenatide prolonged release (weekly) - April 2012

FreeStyle Libre® 

FreeStyle Libre - Recommendation document

FreeStyle Libre - Information for patients (FAQs)

FreeStyle Libre - Patient Contract template – adults

FreeStyle Libre - Patient Contract template – children

FreeStyle Libre - Primary Care Guidance

FreeStyle Libre - Primary Care Information Sheet

FreeStyle Libre - GP letter template – Initiation

FreeStyle Libre - GP letter template – Continuation

FreeStyle Libre - GP letter template – Discontinuation

FreeStyle Libre - Secondary Care Guidance




GLP-1 Analogue added to insulin - July 2012
          GLP-1 Analogue added to insulin - July 2012 (shared care guidelines)
          GLP-1 Analogue added to insulin - July 2012 (template letter & reply slip for shared care guidelines)
Human insulin & insulin analogues in T2DM - July 2012 (patient selection criteria)
Ibandronic acid for bone metastases in Breast Cancer - September 2011 - Please see Malignant disease and immunosupression
Insulin aspart (Fiasp) for diabetes
Insulin degludec (Tresiba) decision document
Insulin Degludec - prescribing support document
insulin glargine 300units (Toujeo) for diabetes
Insulin glargine Biosimilar (Abasaglar) for diabetes
insulin lispro (Humalog 200) for diabetes

Liothyronine position statement and support for primary care review
Liothyronine for hypothyroidism

Liraglutide for obesity in adults
Liraglutide for type 2 diabetes mellitus - November 2010
Lixisenatide for type 2 diabetes mellitus - September 2013
Midodrine for severe orthostatic hypotension due to autonomic dysfunction
Osteoporosis guidelines - February 2015 (long)
Osteoporosis guidelines - February 2015 (short)
Plenadren (Hydrocortisone MR) for adrenal insufficiency - April 2013
Prednisolone E/C tablets - November 2010
Raloxifene and Tamoxifen for familial breast cancer - September 2013 - Please see Malignant disease and immunosupression
Saxagliptin-dapagliflozin (Qtern) for type 2 diabetes
Semaglutide for Type 2 Diabetes in adults
SGLT-2 inhibitor comparison document
Somatostatin Analogues in Acromegaly - November 2011 updated September 2013 (shared care guidance)
Somatropin in children - February 2011
          Somatropin in children (shared care guidelines - GOS)
Tamoxifen and Raloxifene for familial breast cancer - September 2013 - Please see Malignant disease and immunosupression
Testosterone (Nebido) (interim use) - November 2011
Testosterone (Nebido) Prescribing Support
Testosterone (Tostan) gel in male Hypogonadism - November 2012
Tolvaptan for autosomal dominant polycystic kidney disease in adults - December 2015
Tolvaptan for hyponatraemia secondary to SIADH
Vertebroplasty & Balloon Kyphoplasty for Osteoporotic Vertebral Fractures - June 2013

Last modified: 

29 Apr 2020